Annelise Vuidepot
Chief Technology Officer Immunocore
Seminars
Tuesday 19th May 2026
Expanding the Potential of TCR-Based T-Cell Engagers into Infectious Diseases
10:00 am
- Sharing early clinical data on TCR-based bispecific molecules developed to treat HBV and HIV
- Analyzing the pharmacokinetics and pharmacodynamics associated with this mechanism of action
- Highlighting the differences from oncology that emerge due to a lack of suppressive tumor microenvironment
Tuesday 19th May 2026
C-Level Fireside Chat: Reflecting on Lessons from TCR Therapies to Drive Next-Generation Strategies
9:00 am
- Identifying pivotal learnings that can sharpen development strategies and accelerate stronger clinical outcomes
- Framing actionable insights that translate early proof-of-concept gains into durable, real-world clinical impact
- Exploring critical knowledge gaps and defining high-value priorities that can shape the next-generation of TCR innovations
